| Medical and Health Sciences | 2021-2025 | 90 | US 34 | 99.98 |
| Cardiology and Cardiovascular Medicine | Lifetime | 288 | US 167 | 99.63 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 756 | US 398 | 97.34 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 15 | US 8 | 99.93 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 99 | US 52 | 98.59 |
| Hematology | 2021-2025 | 179 | US 85 | 94.53 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 625 | US 216 | 92.67 |
| Medical Physiology | 2021-2025 | 865 | US 314 | 85.45 |
| Cardiovascular Function and Risk Factors | Lifetime | 206 | US 131 | 99.59 |
| Heart Failure Treatment and Management | Lifetime | 112 | US 62 | 99.56 |
| Potassium and Related Disorders | Lifetime | 38 | US 25 | 99.11 |
| Diabetes Treatment and Management | Lifetime | 261 | US 107 | 98.94 |
| Electrolyte and hormonal disorders | Lifetime | 129 | US 60 | 98.43 |
| Cardiac pacing and defibrillation studies | Lifetime | 395 | US 200 | 98.81 |
| Mechanical Circulatory Support Devices | Lifetime | 508 | US 299 | 97.93 |
| Medication Adherence and Compliance | Lifetime | 176 | US 108 | 97.16 |
| Cardiac Health and Mental Health | Lifetime | 549 | US 268 | 96.54 |
| Cardiovascular and exercise physiology | Lifetime | 820 | US 293 | 96.94 |
| Erythropoietin and Anemia Treatment | Lifetime | 218 | US 88 | 96.45 |
| Heart rate and cardiovascular health | Lifetime | 134 | US 47 | 91.09 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 28 | US 14 | 99.81 |
| Heart Failure Treatment and Management | 2021-2025 | 21 | US 12 | 99.85 |
| Medication Adherence and Compliance | 2021-2025 | 9 | US 5 | 98.04 |
| Iron Metabolism and Disorders | 2021-2025 | 16 | US 8 | 98.75 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 44 | US 18 | 99.34 |
| Cardiac Health and Mental Health | 2021-2025 | 25 | US 11 | 98.21 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 6 | US 4 | 99.32 |
| Potassium and Related Disorders | 2021-2025 | 8 | US 5 | 99.31 |
| Diabetes Treatment and Management | 2021-2025 | 85 | US 43 | 99.03 |
| Cardiovascular and exercise physiology | 2021-2025 | 104 | US 23 | 97.10 |
| Electrolyte and hormonal disorders | 2021-2025 | 46 | US 15 | 95.04 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 766 | US 248 | 94.11 |
| Frailty in Older Adults | 2021-2025 | 580 | US 118 | 91.33 |
| Hormonal Regulation and Hypertension | 2021-2025 | 305 | US 66 | 90.30 |
| Pharmaceutical Practices and Patient Outcomes | 2021-2025 | 841 | US 209 | 84.34 |
| Statistical Methods in Clinical Trials | 2021-2025 | 918 | US 390 | 67.85 |
| Renal function and acid-base balance | 2021-2025 | 500 | US 149 | 63.12 |
